Ipca Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is HYDROCHLOROTHIAZIDE USP, with a corresponding US DMF Number 16707.
Remarkably, this DMF maintains an Active status since its submission on July 07, 2003, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 11, 2012, and payment made on December 05, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II